Fish Oil-Derived Fatty Acids in Pregnancy and Wheeze and Asthma in Offspring
Bisgaard H, Stokholm J, Chawes BL, Vissing NH, Bjarnadóttir E, Schoos AM, Wolsk HM, Pedersen TM, Vinding RK, Thorsteinsdóttir S, Følsgaard NV, Fink NR, Thorsen J, Pedersen AG, Waage J, Rasmussen MA, Stark KD, Olsen SF, Bønnelykke K
The New England journal of medicine · 339 citas
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Eventos clínicos como enfermedad o muerte
Quién lo pagó
- Financiación
- Posiblemente financiado por la industria
- Organización sin fines de lucro
- Lundbeckfonden
- Empresa
- Lundbeck Foundation
- Subvenciones
- Lundbeckfonden (R16-2007-1694)
Según 2 financiadores declarados.
Publicación
- Publicado
- 2016-12-28 · N Engl J Med · vol. 375 · número 26 · págs. 2530–2539
- Editorial
- Massachusetts Medical Society
- Citado
- 461 citas · más que el 100% de estudios similares · 37.3× el promedio de su campo
- Impacto
- Entre el 10 % más citado de su campo
- Referencias
- 35 trabajos
- Acceso
- Lectura gratuita
- Áreas de investigación
- Neonatal Respiratory Health Research · Fatty Acid Research and Health · Delphi Technique in Research
- Palabras clave
- Wheeze, Offspring, Fish oil, Polyunsaturated fatty acid, Asthma, Pregnancy, Long chain, Fish <Actinopterygii>, Medicine, Risk factor, Environmental health, Physiology, Internal medicine, Biology, Fatty acid, Chemistry, Biochemistry, Fishery
- MeSH
- humans, respiratory tract infections, asthma, respiratory sounds, fatty acids, omega-3, fish oils, risk, follow-up studies, double-blind method, pregnancy, pregnancy trimester, third, dietary supplements, child, preschool, female, male, medication adherence, kaplan-meier estimate, olive oil
19 autores
- Hans Bisgaard🇩🇰University of Copenhagen; Gentofte Hospital; Copenhagen Prospective Studies on Asthma in Childhood
- Jakob Stokholm🇩🇰University of Copenhagen; Gentofte Hospital; Næstved Sygehus; Copenhagen Prospective Studies on Asthma in Childhood
- Bo Chawes🇩🇰University of Copenhagen; Gentofte Hospital; Copenhagen Prospective Studies on Asthma in Childhood
- Nadja Hawwa Vissing🇩🇰University of Copenhagen; Gentofte Hospital; Copenhagen Prospective Studies on Asthma in Childhood
- Elín Bjarnadóttir🇩🇰University of Copenhagen; Gentofte Hospital; Næstved Sygehus; Copenhagen Prospective Studies on Asthma in Childhood
- Ann‐Marie Malby Schoos🇩🇰University of Copenhagen; Gentofte Hospital; Copenhagen Prospective Studies on Asthma in Childhood
- Helene Mygind Wolsk🇩🇰University of Copenhagen; Gentofte Hospital; Copenhagen Prospective Studies on Asthma in Childhood
- Tine Marie Pedersen🇩🇰University of Copenhagen; Gentofte Hospital; Næstved Sygehus; Copenhagen Prospective Studies on Asthma in Childhood
- Rebecca Vinding🇩🇰University of Copenhagen; Gentofte Hospital; Næstved Sygehus; Copenhagen Prospective Studies on Asthma in Childhood
- Sunna Thorsteinsdóttir🇩🇰University of Copenhagen; Gentofte Hospital; Copenhagen Prospective Studies on Asthma in Childhood
- Nilofar Vahman Følsgaard🇩🇰University of Copenhagen; Gentofte Hospital; Copenhagen Prospective Studies on Asthma in Childhood
- Nadia Rahman Fink🇩🇰University of Copenhagen; Gentofte Hospital; Copenhagen Prospective Studies on Asthma in Childhood
- Jonathan Thorsen🇩🇰University of Copenhagen; Gentofte Hospital; Copenhagen Prospective Studies on Asthma in Childhood
- Anders Gorm Pedersen🇩🇰Copenhagen Prospective Studies on Asthma in Childhood; Technical University of Denmark
- Johannes Waage🇩🇰University of Copenhagen; Gentofte Hospital; Copenhagen Prospective Studies on Asthma in Childhood
- Morten Arendt Rasmussen🇩🇰University of Copenhagen; Gentofte Hospital; Copenhagen Prospective Studies on Asthma in Childhood
- Ken D. Stark🇨🇦🇩🇰University of Waterloo; Copenhagen Prospective Studies on Asthma in Childhood
- Sjurdur Frodi Olsen🇩🇰🇺🇸Statens Serum Institut; Harvard University; Copenhagen Prospective Studies on Asthma in Childhood
- Klaus Bønnelykke🇩🇰University of Copenhagen; Gentofte Hospital; Copenhagen Prospective Studies on Asthma in Childhood
Resumen
El texto original del estudio, en el idioma en que se publicó.
Background
Reduced intake of n-3 long-chain polyunsaturated fatty acids (LCPUFAs) may be a contributing factor to the increasing prevalence of wheezing disorders. We assessed the effect of supplementation with n-3 LCPUFAs in pregnant women on the risk of persistent wheeze and asthma in their offspring.
Methods
We randomly assigned 736 pregnant women at 24 weeks of gestation to receive 2.4 g of n-3 LCPUFA (fish oil) or placebo (olive oil) per day. Their children formed the Copenhagen Prospective Studies on Asthma in Childhood2010 (COPSAC2010) cohort and were followed prospectively with extensive clinical phenotyping. Neither the investigators nor the participants were aware of group assignments during follow-up for the first 3 years of the children's lives, after which there was a 2-year follow-up period during which only the investigators were unaware of group assignments. The primary end point was persistent wheeze or asthma, and the secondary end points included lower respiratory tract infections, asthma exacerbations, eczema, and allergic sensitization.
Results
A total of 695 children were included in the trial, and 95.5% completed the 3-year, double-blind follow-up period. The risk of persistent wheeze or asthma in the treatment group was 16.9%, versus 23.7% in the control group (hazard ratio, 0.69; 95% confidence interval [CI], 0.49 to 0.97; P=0.035), corresponding to a relative reduction of 30.7%. Prespecified subgroup analyses suggested that the effect was strongest in the children of women whose blood levels of eicosapentaenoic acid and docosahexaenoic acid were in the lowest third of the trial population at randomization: 17.5% versus 34.1% (hazard ratio, 0.46; 95% CI, 0.25 to 0.83; P=0.011). Analyses of secondary end points showed that supplementation with n-3 LCPUFA was associated with a reduced risk of infections of the lower respiratory tract (31.7% vs. 39.1%; hazard ratio, 0.75; 95% CI, 0.58 to 0.98; P=0.033), but there was no statistically significant association between supplementation and asthma exacerbations, eczema, or allergic sensitization.
Conclusions
Supplementation with n-3 LCPUFA in the third trimester of pregnancy reduced the absolute risk of persistent wheeze or asthma and infections of the lower respiratory tract in offspring by approximately 7 percentage points, or one third. (Funded by the Lundbeck Foundation and others; ClinicalTrials.gov number, NCT00798226 .).
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.